The Florida PDMP Foundation, Inc. announces a telephone conference call to which all persons are invited.
DATE AND TIME: January 19, 2012; February 16, 2012; March 15, 2012; April 19, 2012; May 17, 2012; June 21, 2012; July 19, 2012; August 16, 2012; September 20, 2012; October 18, 2012; November 15, 2012; and December 20, 2012,
4:00 p.m. - 5:00 p.m. ET
PLACE: Via Conference Call 1(888)808-6959, Conference code: 3662527158
GENERAL SUBJECT MATTER TO BE CONSIDERED: The General Business of The Florida PDMP Foundation, Inc.
A copy of the agenda may be obtained by contacting: The Florida PDMP Foundation, Inc., www.flpdmpfoundation.com. The public agenda will be available two days prior to the meeting date on this website.
Pursuant to the provisions of the Americans with Disabilities Act, any person requiring special accommodations to participate in this workshop/meeting is asked to advise the agency at least 10 days before the meeting by contacting: the Prescription Drug Monitoring Program at (850)245-4797. If you are hearing or speech impaired, please contact the agency using the Florida Relay Service, 1(800)955-8771 (TDD) or 1(800)955-8770 (Voice).
For more information, you may contact: The Florida PDMP Foundation, Inc., C/O Florida Prescription Drug Monitoring Program, 4052 Bald Cypress Way, C-16, Tallahassee, FL 32399 or (850)245-4797.
The General Business of The Florida PDMP Foundation, Inc.; January 19, 2012; February 16, 2012; March 15, 2012; April 19, 2012; May 17, 2012; June 21, 2012; July 19, 2012; August 16, 2012; September 20, 2012; October 18, 2012; November 15, 2012; and ...
Document Information
- Hearing Meeting:
- Via Conference Call 1(888)808-6959, Conference code: 3662527158
- Subject:
- The General Business of The Florida PDMP Foundation, Inc.
- Meeting:
- telephone conference call
- Contact:
- The Florida PDMP Foundation, Inc., www.flpdmpfoundation.com. The public agenda will be available two days prior to the meeting date on this website. Pursuant to the provisions of the Americans with Disabilities Act, any person requiring special accommodations to participate in this workshop/meeting is asked to advise the agency at least 10 days before the meeting by contacting: the Prescription Drug Monitoring Program at (850)245-4797. If you are hearing or speech impaired, please contact the ...